What Is CBDV (Cannabidivarin)? A Guide for B2B Brands

CBDV (cannabidivarin) is a non-intoxicating hemp cannabinoid structurally related to CBD, distinguished by a shorter propyl side chain in place of CBD's pentyl chain. It occurs at low concentrations in most commercial hemp cultivars and at comparatively higher levels in a small number of landrace varieties not widely grown in the United States. That scarcity is the defining fact for B2B buyers: CBDV is federally legal and chemically well understood, but commercial availability is limited and pricing reflects it. This guide covers what CBDV is, how it compares to CBD, who is actually sourcing it, and what to expect when evaluating it as a wholesale ingredient. For bulk specs, sizes and sourcing, see the CBDV distillate and isolate sourcing guide.

What Is CBDV and Where Does It Come From?

Cannabidivarin is one of more than 100 cannabinoids identified in the Cannabis sativa plant. It belongs to the same broad chemical family as CBD, sharing the core cannabinoid ring structure, but differs in the length of its alkyl side chain. This same propyl-versus-pentyl distinction defines the relationship between THC and THCV, making CBDV the non-intoxicating counterpart in a structural pattern seen elsewhere in cannabinoid chemistry.

In most commercial hemp cultivars grown in the United States, CBDV is present only in trace amounts. Certain landrace and indigenous cannabis varieties, historically associated with regions including parts of India, Pakistan, Nepal, and Africa, have been documented to carry comparatively higher relative concentrations of CBDV. These varieties are not the cultivars driving commercial U.S. hemp production, which is one reason CBDV has remained a minor cannabinoid in the wholesale market even as interest in it has grown.

"The plant species Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis."

U.S. Department of Agriculture, Agricultural Marketing Service, Domestic Hemp Production Program, 7 CFR 990.1, implementing the Agriculture Improvement Act of 2018 (Pub. L. 115-334)

CBDV vs. CBD: The Structural Difference

CBD and CBDV share a core structure but differ in side chain length and plant abundance

This structural relationship matters for formulators because side chain length affects how a cannabinoid interacts with biological receptors, but it does not change CBDV's basic legal or safety classification relative to CBD. Both are non-intoxicating cannabinoids subject to the same hemp compliance framework. The practical difference for a B2B buyer is availability and cost, not legal status or general handling.

Why CBDV Is Scarce and Expensive

Two factors compound to make CBDV one of the more difficult cannabinoids to source at commercial volume.

Low concentration in commercial cultivars. The hemp varieties grown at scale in the United States have been bred predominantly for CBD content, not CBDV. CBDV is present in these cultivars only in trace amounts, which means extracting commercially meaningful quantities from standard U.S. hemp biomass is not economically practical at current cultivar genetics.

Limited cultivation of CBDV-elevated genetics. The landrace varieties associated with higher relative CBDV content are not widely cultivated domestically at commercial scale. Sourcing CBDV at meaningful volume typically requires either specialized genetics programs or biomass sourced from regions where these varieties are more established, both of which add cost and complexity relative to standard CBD sourcing.

Commercial Availability: Distillate and Isolate

CBDV is available in distillate and isolate formats, though stocking is inconsistent across the supplier landscape given the underlying scarcity described above. CBDV isolate shares CBD's general physical characteristics as a crystalline solid, behaving similarly to CBD isolate in formulation handling once dissolved into a carrier. CBDV distillate retains minor cannabinoids and terpenes from the source extract alongside the concentrated CBDV fraction.

For specific format availability, current potency ranges, and pricing, see our dedicated guide to CBDV distillate and isolate sourcing. Given the volatility in CBDV supply, that guide is the better reference point for transaction-level decisions than general potency figures, which can shift as new lots and genetics enter the market.

Who Is Actually Sourcing CBDV

CBDV's buyer base is narrower and more specific than CBD, CBG, or even CBC. Three categories of buyer make up most of the current demand:

• Novelty and innovation-positioned brands. Brands building a product line around cannabinoid rarity and formulation sophistication use CBDV as a differentiation ingredient, often at low inclusion rates alongside CBD as the cost base.
• Specialty and research-adjacent formulators. Companies building products informed by ongoing cannabinoid research interest in CBDV, distinct from the broader consumer wellness market.
• Multi-cannabinoid blend developers. Brands assembling complex cannabinoid panels for premium product lines where CBDV is one of several rare cannabinoids included for label differentiation.

For most volume-focused B2B buyers building standard tinctures, gummies, or topicals, CBDV is not the right starting cannabinoid. CBD, CBG, and CBN offer more reliable supply, lower cost, and broader market familiarity.

How CBDV Is Sourced: Order Sizes, Lead Times and What to Expect

Bulk CBDV is usually sold from 100g to 1kg upward, and suppliers typically quote it on a current-lot basis because supply is volatile. Lead times for CBDV can run longer than for CBD, CBG, or CBN given the smaller and less consistent supplier base.

Before building a product development timeline around CBDV as a required ingredient, confirm current availability, realistic lead time, and pricing for your specific volume with your supplier.

What This Means for Your Business

CBDV is a legitimate, federally compliant cannabinoid with genuine appeal for brands whose positioning depends on cannabinoid novelty and formulation sophistication. It is not a cannabinoid to build a core product line around given current supply constraints, and any brand considering it should treat sourcing risk as the central planning variable rather than an afterthought.

The practical sequence for evaluating CBDV is: confirm current lot availability and pricing with a supplier before finalizing a formulation, build the product around realistic inclusion rates given the cost premium, and have a fallback formulation plan that does not depend on CBDV in case supply tightens between development and launch. Brands that treat CBDV as a confirmed, locked-in ingredient before validating supply consistently run into timeline problems.

For brands exploring the full minor and rare cannabinoid landscape, CBDV sits alongside CBC, CBDA, and CBGA as part of a broader trend toward cannabinoid-diverse product positioning. The economics and sourcing considerations differ across each, and treating them as a single category obscures real differences in availability and cost.

To see how CBDV fits alongside CBG, CBC, CBN and the acid forms, read Minor and Rare Cannabinoids Explained.

Frequently Asked Questions

By John Piccone | Bulk CBD Distributors | bulkcbddistributors.com